230 related articles for article (PubMed ID: 31705251)
21. [Chronic pancreatitis : Characterization and differentiation from pancreatic cancer].
Kristic A; Bastati N; Poetter-Lang S; Messner A; Herold A; Tamandl D; Ba-Ssalamah A
Radiologe; 2021 Jun; 61(6):563-571. PubMed ID: 34002282
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Ren S; Zhao R; Zhang J; Guo K; Gu X; Duan S; Wang Z; Chen R
Abdom Radiol (NY); 2020 May; 45(5):1524-1533. PubMed ID: 32279101
[TBL] [Abstract][Full Text] [Related]
23. Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas.
Kersting S; Konopke R; Kersting F; Volk A; Distler M; Bergert H; Saeger HD; Grützmann R; Bunk A
Gastroenterology; 2009 Dec; 137(6):1903-11. PubMed ID: 19715694
[TBL] [Abstract][Full Text] [Related]
24. [Imaging of chronic pancreatitis].
Vullierme MP
Rev Prat; 2018 Jun; 68(6):665-668. PubMed ID: 30869261
[TBL] [Abstract][Full Text] [Related]
25. CT and MR features that can help to differentiate between focal chronic pancreatitis and pancreatic cancer.
Srisajjakul S; Prapaisilp P; Bangchokdee S
Radiol Med; 2020 Apr; 125(4):356-364. PubMed ID: 31933064
[TBL] [Abstract][Full Text] [Related]
26. Atypical and uncommon CT and MR imaging presentations of pancreatic ductal adenocarcinoma.
Gong XH; Xu JR; Qian LJ
Abdom Radiol (NY); 2021 Sep; 46(9):4226-4237. PubMed ID: 33914139
[TBL] [Abstract][Full Text] [Related]
27. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.
Guo C; Zhuge X; Wang Q; Xiao W; Wang Z; Wang Z; Feng Z; Chen X
Cancer Imaging; 2018 Oct; 18(1):37. PubMed ID: 30333055
[TBL] [Abstract][Full Text] [Related]
28. Use of MDCT to Differentiate Autoimmune Pancreatitis From Ductal Adenocarcinoma and Interstitial Pancreatitis.
Lee-Felker SA; Felker ER; Kadell B; Farrell J; Raman SS; Sayre J; Lu DS
AJR Am J Roentgenol; 2015 Jul; 205(1):2-9. PubMed ID: 26102377
[TBL] [Abstract][Full Text] [Related]
29. 64-slice CT perfusion imaging of pancreatic adenocarcinoma and mass-forming chronic pancreatitis.
Lu N; Feng XY; Hao SJ; Liang ZH; Jin C; Qiang JW; Guo QY
Acad Radiol; 2011 Jan; 18(1):81-8. PubMed ID: 20951612
[TBL] [Abstract][Full Text] [Related]
30. Imaging mimics of pancreatic ductal adenocarcinoma.
Gandhi NS; Feldman MK; Le O; Morris-Stiff G
Abdom Radiol (NY); 2018 Feb; 43(2):273-284. PubMed ID: 29038855
[TBL] [Abstract][Full Text] [Related]
31. [Tumor-like lesion of the pancreas in chronic pancreatitis : imaging characteristics of computed tomography].
Zech CJ; Bruns C; Reiser MF; Herrmann KA
Radiologe; 2008 Aug; 48(8):777-84. PubMed ID: 18604517
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
[TBL] [Abstract][Full Text] [Related]
33. Malignancy in chronic pancreatitis: analysis of diagnostic procedures and proposal of a clinical algorithm.
Rückert F; Brussig T; Kuhn M; Kersting S; Bunk A; Hunger M; Saeger HD; Niedergethmann M; Post S; Grützmann R
Pancreatology; 2013; 13(3):243-9. PubMed ID: 23719595
[TBL] [Abstract][Full Text] [Related]
34. Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions.
Deng Y; Ming B; Zhou T; Wu JL; Chen Y; Liu P; Zhang J; Zhang SY; Chen TW; Zhang XM
Front Oncol; 2021; 11():620981. PubMed ID: 33842325
[TBL] [Abstract][Full Text] [Related]
35. The abrupt pancreatic duct cutoff sign on MDCT and MRI.
Johnston A; Serhal A; Lopes Vendrami C; McCarthy RJ; Komanduri S; Horowitz JM; Nikolaidis P; Miller FH
Abdom Radiol (NY); 2020 Aug; 45(8):2476-2484. PubMed ID: 32444890
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of pancreatic ductal adenocarcinoma from inflammatory mass: added value of magnetic resonance elastography.
Liu Y; Wang M; Ji R; Cang L; Gao F; Shi Y
Clin Radiol; 2018 Oct; 73(10):865-872. PubMed ID: 29895389
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic cancer in patients with chronic calcifying pancreatitis: Computed tomography findings - a retrospective analysis of 48 patients.
Mohamed A; Ayav A; Belle A; Orry X; Chevaux JB; Laurent V
Eur J Radiol; 2017 Jan; 86():206-212. PubMed ID: 28027749
[TBL] [Abstract][Full Text] [Related]
38. [Ductal adenocarcinoma and unusual differential diagnosis].
Haage P; Schwartz CA; Scharwächter C
Radiologe; 2016 Apr; 56(4):325-37. PubMed ID: 27000276
[TBL] [Abstract][Full Text] [Related]
39. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
[TBL] [Abstract][Full Text] [Related]
40. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas.
Ichikawa T; Sou H; Araki T; Arbab AS; Yoshikawa T; Ishigame K; Haradome H; Hachiya J
Radiology; 2001 Oct; 221(1):107-16. PubMed ID: 11568327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
